# Insilico Medicine Cayman TopCo — Form D

Insilico Medicine Cayman TopCo of HONG KONG, K3, a company, filed a Form D exempt-offering notice with the SEC on 2019-09-24. The offering totals $36.8M, of which $36.8M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-09-24
- Form: D
- Accession: 0001789097-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $36.8M
- Amount sold: $36.8M
- Investors: 21
- Date of first sale: 2019-09-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-349539

## Issuer

- Name: Insilico Medicine Cayman TopCo
- CIK: 0001789097
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: RM 8 UNIT 111-113 ICT CO-WORKING CENTRE, HONG KONG, K3, 00000
- Phone: 16265937957

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Lennart Lee | Director | Trade Zone Shanghai, F4 |
| Nisa Leung | Director | Bellevue, WA |
| James Mellon | Director | New York, NY |
| \[none\] WNL Limited | Director | Grand Cayman, E9 |
| Alex Zavoronkov | Director | Rockville, MD |

## More

- [CIK 1789097 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1789097&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001789097-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.